secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inotiv, Inc. (NOTV)
CIK:        0000720154
Form:       8-K
Filed at:   2021-09-28T23:59:59+00:00
Accession:  0001558370-21-012840
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inotiv provides Q1 2021 financials for Bolder BioPATH & HistoTox; CCO Flynn departs with severance
--------------------------------------------------------------------------------

- Bolder BioPATH Q1 2021 net income $868K, revenue $3.74M; acquired for $18.5M cash, $1.5M notes, $34.5M in shares in May 2021.
- HistoTox Labs Q1 2021 net income $962K, revenue $2.62M; acquired for $22.3M cash in April 2021.
- Former CCO Joseph Flynn terminated Sep 8; severance includes 4-month salary continuation, COBRA reimbursement.
- Flynn forfeits unvested options/RSUs, can exercise 7,000 options until Oct 8, 2021.
- Non-solicitation obligation reduced from 24 to 6 months; mutual non-disparagement and release of claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/720154/000155837021012840/0001558370-21-012840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/720154/000155837021012840/notv-20210927x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-012840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer